Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-24

Clinical Trial Update: Xanthohumol and Metabolic Syndrome

View source ↗

Summary

A clinical trial evaluating xanthohumol for metabolic syndrome has completed. The sponsor listed is Oregon State University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xanthohumol (Xanthohumol)

Snippet

Sponsor: Oregon State University | Conditions: Metabolic Syndrome | Status: COMPLETED